Kevin Kabat, Fifth Third Bancorp president & CEO, discusses the bank's quarterly earnings and the current regulatory environment in financials. Serving our customers is a key cog in helping move the economy forward, says Kabat.» Read More
Children's Place Retail Stores Wednesday fired Chief Executive Ezra Dabah and named board member Chuck Crovitz as interim CEO, sending its shares up as much as 9 percent.
The Department of Transportation also proposed four new daily flights to China to begin in 2009. These flights would be operated by AMR's American Airlines, Continental Airlines, Northwest Airlines, and US Airways.
Four out of five businesses worldwide have been hurt by some type of corporate fraud in the last three years, according to a survey commissioned by risk consultant Kroll.
Prosecutors reached a plea deal earlier this week with Weiss's former partner, William Lerach, who along with Weiss helped shape the class-action legal industry and its pursuit of corporations for alleged wrongdoing.
South Korea will loosen regulations on foreign asset management firms and domestic private equity funds as early as this year, the finance ministry said on Thursday.
A panel of advisers to U.S. health regulators voted on Tuesday to reject new restrictions on anemia drugs, a win for drugmakers Amgen and Johnson & Johnson .
An all out battle will soon be joined by Sallie Mae and its bankers on one side and the private equity firm of J.C. Flowers and its banks and co-investors J.P. Morgan and BankAmerica.
Is the Senate coming to the rescue of patients, investors or both? That's the question being raised after the passage of a non-binding resolution telling Medicare to "immediately reconsider" its new policy to cut anemia drug use and reimbursement. Analysts are stunned by the move.
Half a dozen states are working together to investigate rating agencies, banks and other players that benefited from the onetime boom in subprime mortgages that has since turned into a meltdown, Ohio Attorney General Marc Dann told Reuters.
Greece's Public Power Corp. SA has been given general approval to replace its stock of aging power generation facilities, the government said Saturday.
CNBC has learned that Maurice "Hank" Greenberg has received a subpoena from the SEC and will be giving his first deposition as part of the SEC’s continuing investigation into what role, if any, he played in alleged accounting improprieties at American International Group.
Merck said Thursday the New Jersey Supreme Court has reversed a lower court ruling that had granted nationwide class-action status to insurers seeking reimbursement for past spending on Vioxx, the drugmaker's withdrawn arthritis treatment.
The Securities and Exchange Commission said Wednesday that Saks Inc. has agreed to settle a lawsuit that Saks Fifth Avenue understated sales to some vendors and didn't record markdowns properly, inflating its earnings.
Intel Corp. plans to respond quickly to a U.S. Federal Trade Commission request for more information on a plan to merge its flash memory chip business with that of Switzerland's STMicroelectronics NV.
The worst housing slump in 16 years and upheaval in financial markets have cast a shadow on the economy, leading lawmakers to question federal regulators about the path ahead for anxious consumers.
Biovail said Tuesday it received Canadian approval for its once-daily, extended-release formulation of its tramadol pain treatment, giving the stock a much-needed dose of positive news.
Sweden's Financial Supervisory Authority (FI) said it would investigate to see if OMX used inappropriate defense measures after Borse Dubai launched an unsolicited bid for the exchange owner.
The U.S. Consumer Product Safety Commission is investigating the timeliness of toy company Mattel's disclosures before its most recent recall, the Wall Street Journal reported in its online edition on Tuesday.
Children's Place Retail Stores said Friday it secured a licensing agreement with Walt Disney that had been in jeopardy.
Benefits of an experimental AIDS drug developed by Merck & Co appear to outweigh risks, according to U.S. Food and Drug Administration staff documents released Friday ahead of an advisory panel meeting.